Publications
Title
Info
2020
-
LP2, the first lanthipeptide GPCR agonist in a human pharmacokinetics and safety studyNamsolleck P, Richardson A, Moll GN, Mescheder A. Peptides 136, 170468
-
Biosynthesis of lanthionine-constrained agonists of G protein-coupled receptors.Moll GN, Kuipers A, Rink R, Bosma T, de Vries L, Namsolleck P. Biochem Soc Trans. 48, 2195-2203
-
Does activation of the protective Renin-Angiotensin System have therapeutic potential in COVID-19?Namsolleck P, Moll GN. Mol Med. 26, 80
-
High-Throughput Screening for Substrate Specificity-Adapted Mutants of the Nisin Dehydratase NisB.Zhao X, Cebrián R, Fu Y, Rink R, Bosma T, Moll GN, Kuipers OP. ACS Synth Biol. 9, 1468-1478
-
Cyclic angiotensin-(1-7) contributes to rehabilitation of animal performance in a rat model of cerebral stroke.Kuipers, A., Moll, G.N., Levy, A., Krakovsky, M., Franklin, R. Peptides 123, 170193
2019
-
Genetically Encoded Libraries of Constrained Peptides.Bosma, T., Rink, R., Moosmeier, M.A., Moll, G.N. Chembiochem 20, 1754-1758
-
Efficacy of lanthionine-stabilized angiotensin-(1-7) in type I and type II diabetes mouse models.Kuipers A, Moll GN, Wagner E, Franklin R. Peptides. 112, 78-84
2017
-
Mutagenesis of nisin's leader peptide proline strongly modulates export of precursor nisin.Plat, A., Kuipers, A., Crabb, J., Rink, R., Moll, G.N. Antonie Van Leeuwenhoek 110, 321-330.
-
Mechanistic aspects of lanthipeptide leaders.Plat, A., Kuipers, A., Rink, R., Moll, G.N. Curr. Protein Pept. Sci. 14, 85-96.
-
Phage display and selection of lanthipeptides on the carboxy-terminus of the gene-3 minor coat protein.Urban J.U., Moosmeier, M.A., Aumüller, T., Thein, M., Bosma, T., Rink, R., Groth, K., Zulley, M., Siegers, K., Tissot, K., Moll, G.N., Prassler, J.Nature Comm. 2017 Nov 15;8(1):1500
-
Semi-microbiological synthesis of an active lysinoalanine-bridged analog of glucagon-like-peptide-1.Kuipers, A., de Vries, L., de Vries, M.P., Rink, R., Bosma, T., Moll, G.N. Peptides 91, 33-39.
2015
-
GRPR-selective PET imaging of prostate cancer using [(18)F]-lanthionine-bombesin analogs.Carlucci, G., Kuipers, A., Ananias, H.J., de Paula Faria, D., Dierckx, R.A., Helfrich, W., Rink, R., Moll, G.N., de Jong IJ, Elsinga PH. Peptides 67, 45-54.
2012
-
Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.Wagenaar, G.T., Laghmani, E.H., Fidder, M., Sengers, R.M., de Visser, Y.P., de Vries, L., Rink, R., Roks, A,J., Folkerts, G., Walther, F.J.
-
The effect of the thioether-bridged, stabilized Angiotensin-(1-7) analogue cyclic ang-(1-7) on cardiac remodeling and endothelial function in rats with myocardial infarction.Durik, M., van Veghel, R., Kuipers, A., Rink, R, Haas, Jimoh Akanbi, M., Moll, G., Danser, A.H., Roks, A.J. Int J Hypertens 2012, 536426.
2011
-
Bacterial display and screening of posttranslationally thioether-stabilized peptides.Bosma, T., Kuipers, A., Bulten, E., de Vries, L., Rink, R., Moll, G.N. Appl. Environ. Microbiol. 77, 6794-801.
Pages
- 1
- 2